Which treatment option is most commonly used for early-stage breast cancer?

Which treatment option is most commonly used for early-stage breast cancer?

• A. Chemotherapy
• B. Radiation therapy
• C. Surgery
• D. Hormonal therapy

Answer: (C)

Surgery is the most commonly used treatment option for early-stage breast cancer because it aims to remove the tumor and any surrounding tissue that may contain cancerous cells. This approach can range from lumpectomy, where only the tumor and a small margin of surrounding tissue are removed, to mastectomy, where a larger portion or all of the breast may be removed. The goal of surgery is not only to eradicate the cancer but also to preserve as much of the breast as possible when appropriate. In early-stage breast cancer, the disease is generally localized, allowing surgery to be an effective first-line treatment. Following surgery, additional treatments such as radiation therapy, chemotherapy, or hormonal therapy may be used based on the specific characteristics of the cancer and the patient’s overall health. These adjunct treatments are important for reducing the risk of recurrence and addressing any remaining cancer cells, but the primary intervention in the management of early-stage breast cancer remains surgical.

Surgery is the most commonly used treatment option for early-stage breast cancer because it aims to remove the tumor and any surrounding tissue that may contain cancerous cells. This approach can range from lumpectomy, where only the tumor and a small margin of surrounding tissue are removed, to mastectomy, where a larger portion or all of the breast may be removed. The goal of surgery is not only to eradicate the cancer but also to preserve as much of the breast as possible when appropriate.

In early-stage breast cancer, the disease is generally localized, allowing surgery to be an effective first-line treatment. Following surgery, additional treatments such as radiation therapy, chemotherapy, or hormonal therapy may be used based on the specific characteristics of the cancer and the patient’s overall health. These adjunct treatments are important for reducing the risk of recurrence and addressing any remaining cancer cells, but the primary intervention in the management of early-stage breast cancer remains surgical.